Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Optic Nerve.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Products
Acute Multiple Sclerosis Relapse.
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
If they are OK, we are OK: the experience of partners living with neuromyelitis optica.
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists.
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease.
Myeloperoxidase: Bridging the gap in neurodegeneration.
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
The history of myelin.
[Exogenous evoked potentials in adolesccents with muftiple sclerosis].
Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre' syndrome (GBS).
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
A gut (microbiome) feeling about the brain.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.

Pages